- Preview Available
- Scholarly Journal
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killingTesori, Valentina; Piscaglia, Anna Chiara; Samengo, Daniela; Barba, Marta; Bernardini, Camilla
; et al.
Scientific Reports (Nature Publisher Group); London Vol. 5, (Mar 2015): 9149.
DOI:10.1038/srep09149
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.




